DGE's Investigator Initiated Trials Summit| MENAFN.COM

Wednesday, 19 January 2022 10:35 GMT

DGE's Investigator Initiated Trials Summit


(MENAFN- Investor Brand Network)

On February 7-8th, 2022 in Philadelphia, DGE will hold the Investigator Trials Summit, which will provide delegates with the most up-to-date information on the full spectrum of challenges facing the industry: from reviewing proposals and aligning research with the corporation's goals, to closing out studies and handling publication data, all while adhering to strict legal and regulatory frameworks on an international playing field.

The IIT Summit will feature sessions on the industry's most pressing issues, such as multi-centered monitoring, assuring ROI, developing a publication strategy, and learning from practical case studies. Guest speakers, including Pfizer's Alexander Kostek and Actelion Pharmaceuticals' Joelle Rebetez, will lead in-depth and collaborative sessions as well as interactive panel discussions on a variety of timely issues.

The conference will feature a small-group format to encourage greater peer-to-peer networking and promote conversation among…

Read More>>

For more information, please visit .

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you'll need to ensure that your next press release grabs the attention of your target audience and doesn't let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement .

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the  50+ brands that make up the  InvestorBrandNetwork .

Get more out of your next press release with InvestorWire. It's unlike anything you've seen before.

For more information, please visit 

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: 

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office

InvestorWire is part of the InvestorBrandNetwork .

MENAFN14012022000224011066ID1103541370


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.